Gene · 4481
Papers3,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential. | Int J Mol Sci | 2022 | 36555792 | PubTator, text mining | PubMed |
| iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories. | Int J Mol Sci | 2022 | 36555728 | PubTator, text mining | PubMed |
The New General Biological Property of Stem-like Tumor Cells (Part II: Surface Molecules, Which Belongs to Distinctive Groups with Particular Functions, Form a Unique Pattern Characteristic of a Certain Type of Tumor Stem-like Cells). | Int J Mol Sci | 2022 | 36555446 | PubTator, text mining | PubMed |
| Microglia and Brain Macrophages as Drivers of Glioma Progression. | Int J Mol Sci | 2022 | 36555253 | PubTator, text mining | PubMed |
| Innate Immune Memory in Monocytes and Macrophages: The Potential Therapeutic Strategies for Atherosclerosis. | Cells | 2022 | 36552836 | PubTator, text mining | PubMed |
| The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network. | Cancers (Basel) | 2022 | 36551635 | PubTator, text mining | PubMed |
| Activation of OSM-STAT3 Epigenetically Regulates Tumor-Promoting Transcriptional Programs in Cervical Cancer. | Cancers (Basel) | 2022 | 36551576 | PubTator, text mining | PubMed |
| Tumor Microenvironment in Thymic Epithelial Tumors: A Narrative Review. | Cancers (Basel) | 2022 | 36551568 | PubTator, text mining | PubMed |
| Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer. | Cancers (Basel) | 2022 | 36551522 | PubTator, text mining | PubMed |
| TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis. | J Immunother Cancer | 2022 | 36549780 | PubTator, text mining | PubMed |
| An update on epigenetic regulation in autoimmune diseases. | J Transl Autoimmun | 2022 | 36544624 | PubTator, text mining | PubMed |
| Calcium/strontium chloride impregnated zeolite A and X granules as optimized ammonia sorbents. | RSC Adv | 2022 | 36540240 | PubTator, text mining | PubMed |
| Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis. | J Neuroinflammation | 2022 | 36536441 | PubTator, text mining | PubMed |
| The Yin-Yang of myeloid cells in the leukemic microenvironment: Immunological role and clinical implications. | Front Immunol | 2022 | 36532078 | PubTator, text mining | PubMed |
| Resident macrophages of the lung and liver: The guardians of our tissues. | Front Immunol | 2022 | 36532044 | PubTator, text mining | PubMed |
| Comparing the Characteristics of Microglia Preparations Generated Using Different Human iPSC-Based Differentiation Methods to Model Neurodegenerative Diseases. | ASN Neuro | 2022 | 36524236 | PubTator, text mining | PubMed |
| Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment. | Front Endocrinol (Lausanne) | 2022 | 36523601 | PubTator, text mining | PubMed |
| Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification. | Front Cell Dev Biol | 2022 | 36523510 | PubTator, text mining | PubMed |
| Integrated spatial analysis of gene mutation and gene expression for understanding tumor diversity in formalin-fixed paraffin-embedded lung adenocarcinoma. | Front Oncol | 2022 | 36505794 | PubTator, text mining | PubMed |
| Prognostic value of elastic lamina staining in patients with stage III colon cancer. | World J Surg Oncol | 2022 | 36503509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4481/papers?page=36